Skip to content

Drug interactions

Lenacapavir + Upadacitinib

Severity: Moderate

Lenacapavir and Upadacitinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lenacapavir is a moderate CYP3A4 inhibitor and may increase upadacitinib exposure. Its long half-life means the effect may persist for months after dosing.

What this interaction means in plain words

Lenacapavir and Upadacitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lenacapavir belongs to Anti Virals; Upadacitinib belongs to Musculoskeletal.

Evidence level: Low

Why it happens

Lenacapavir inhibits CYP3A4, reducing metabolism of upadacitinib.

What to do

Monitor for infection and cytopenias, and consider upadacitinib dose reduction. Remember the inhibition may persist after the last lenacapavir dose.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lenacapavir and Upadacitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lenacapavir with Upadacitinib?

MediHelp rates the interaction as moderate. Lenacapavir and Upadacitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lenacapavir is a moderate CYP3A4 inhibitor and may increase upadacitinib exposure. Its long half-life means the effect may persist for months after dosing.

How serious is the interaction between Lenacapavir and Upadacitinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for infection and cytopenias, and consider upadacitinib dose reduction. Remember the inhibition may persist after the last lenacapavir dose.

What other medicines interact with Upadacitinib?

MediHelp also lists interactions of Upadacitinib with, for example, Abrocitinib, Adenovirus types 4 and 7 live, Baricitinib. The full list is on the Upadacitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in